-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Anebulo Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2024.
- Anebulo Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $211K, a 236% increase year-over-year.
- Anebulo Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $256K, a 124% increase year-over-year.
- Anebulo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2024 was $107K, a 109% increase from 2023.
- Anebulo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $51.3K, a 823% increase from 2022.
- Anebulo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $5.56K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)